z-logo
Premium
HIV/SARS‐CoV‐2 coinfection: A global perspective
Author(s) -
Kanwugu Osman N.,
Adadi Parise
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26321
Subject(s) - coinfection , pandemic , virology , immunosuppression , coronavirus , medicine , disease , covid-19 , immunology , human immunodeficiency virus (hiv) , infectious disease (medical specialty)
Since its first appearance in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has rapidly spread throughout the world and has become a global pandemic. Several medical comorbidities have been identified as risk factors for coronavirus disease 2019 (COVID‐19). However, it remains unclear whether people living with human immunodefeciency virus (PLWH) are at an increased risk of COVID‐19 and severe disease manifestation, with controversial suggestion that HIV‐infected individuals could be protected from severe COVID‐19 by means of antiretroviral therapy or HIV‐related immunosuppression. Several cases of coinfection with HIV and SARS‐CoV‐2 have been reported from different parts of the globe. This review seeks to provide a holistic overview of SARS‐CoV‐2 infection in PLWH.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here